Scott+Scott Attorneys at Law LLP Announces Investigation into Personalis, Inc. (PSNL)

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, is investigating whether Personalis, Inc. (“Personalis” or the “Company”) (NASDAQ: PSNL) or certain of its officers and directors violated federal securities laws. If you purchased or otherwise own Personalis stock, and have suffered a loss, you are encouraged to contact Scott+Scott attorney Joe Pettigrew for additional information at [phone] or [e-mail].

Personalis is a cancer genomics company based in Menlo Park, California. The Company conducted an initial public offering (“IPO”) in June 2019. Shares were offered at $17.00 per share in the IPO and reached a high of $31.88 immediately following the IPO. Shares closed on April 15, 2020 at $8.57, after reaching a low of $4.27. Our investigation concerns whether Personalis made false and misleading statements and omitted material information in connection with its IPO.

What You Can Do

If you purchased or otherwise own Personalis stock, and you wish to discuss this investigation, please contact attorney Joe Pettigrew at [phone], or at [e-mail].

About Scott+Scott Attorneys at Law LLP

Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Amsterdam, Connecticut, California, and Ohio.

Attorney Advertising